癌/睾丸抗原1B(CTAG1B)重组蛋白

YB316Hu014
Recombinant Cancer/Testis Antigen 1B (CTAG1B)
Organism Species: Homo sapiens (Human)
Instruction manual
FOR IN VITRO USE AND RESEARCH USE ONLY
NOT FOR USE IN CLINICAL DIAGNOSTIC PROCEDURES
10th Edition (Revised in Jan, 2014)
癌/睾丸抗原1B(CTAG1B)重组蛋白[ PROPERTIES ]
Residues: Met1~Arg180
Tags: Two N-terminal Tags, His-tag and T7-tag
Accession: P78358
Host: E. coli
Subcellular Location: Cytoplasm.
Purity: >90%
Endotoxin Level: <1.0EU per 1μg
(determined by the LAL method).
Formulation: Supplied as lyophilized form in PBS,
癌/睾丸抗原1B(CTAG1B)重组蛋白H7.4, containing 5% trehalose, 0.01% sarcosyl.
Predicted isoelectric point: 8.8
Predicted Molecular Mass: 21.7kDa
Applications: SDS-PAGE; WB; ELISA; IP.
(May be suitable for use in other assays to be determined by the end user.)
[ USAGE ]
Reconstitute in sterile PBS, pH7.2-pH7.4.
[ STORAGE AND STABILITY ]
Storage: Avoid repeated freeze/thaw cycles.
Store at 2-8oC for one month.
Aliquot and store at -80oC for 12 months.
Stability Test: The thermal stability is described by the loss rate of the target
protein. The loss rate was determined by accelerated thermal degradation test,
that is, incubate the protein at 37oC for 48h, and no obvious degradation and
precipitation were observed. (Referring from China Biological Products Standard,
癌/睾丸抗原1B(CTAG1B)重组蛋白which was calculated by the Arrhenius equation.) The loss of this protein is less
than 5% within the expiration date under appropriate storage condition.
[ SEQUENCES ]
The sequence of the target protein is listed below.
MQAEGRGTGG STGDADGPGG PGIPDGPGGN AGGPGEAGAT GGRGPRGAGA
ARASGPG GGA PRGP HG GAA S GL NG CC RCGA RGPE S R L LEF YLAMP FATPM
EAELARRSLA QDAPPLPVPG VLLKEFTVSG NILTIRLTAA DHRQLQLSIS SCLQQLSLLM
WITQCFLPVF LAQPPSGQRR